Posterior Cortical Atrophy in the Asia‐Pacific: A Report From the PCA Asian Workgroup
ABSTRACT Objective Posterior Cortical Atrophy (PCA) is a distinct dementia syndrome primarily affecting spatial abilities and visual processing. It is associated with degeneration in the posterior part of the brain. PCA is subclassified into PCA‐pure and PCA‐plus syndromes based on consensus criteria.
Yuttachai Likitjaroen +11 more
wiley +1 more source
RWDisEnh+: Enhancing disease-enhancer association prediction through multiplex-heterogeneous networks. [PDF]
Le DH.
europepmc +1 more source
Epidemic Spreading and Equilibrium Social Distancing in Heterogeneous Networks. [PDF]
Amini H, Minca A.
europepmc +1 more source
Multidimensional Profiling of MRI‐Negative Temporal Lobe Epilepsy Uncovers Distinct Phenotypes
ABSTRACT Objective Although hippocampal sclerosis (TLE‐HS) represents the most frequent cause of temporal lobe epilepsy (TLE), up to 30% of patients show no lesion on visual MRI inspection (TLE‐MRIneg). These cases pose diagnostic and therapeutic challenges and are underrepresented in surgical series.
Alice Ballerini +28 more
wiley +1 more source
An in depth investigation on device-to-device communication in heterogeneous networks: opportunities and challenges. [PDF]
Ali A, Zehra A, Nafees M, Amin MA.
europepmc +1 more source
Identification of Colon Cancer-Related RNAs Based on Heterogeneous Networks and Random Walk. [PDF]
Chen B +4 more
europepmc +1 more source
ABSTRACT Objective To explore how cerebral hypoxia and Normal‐Appearing White Matter (NAWM) integrity affect MS lesion burden and clinical course. Methods Seventy‐nine MS patients, including 13 clinically isolated syndrome (CIS) patients and 66 relapsing–remitting multiple sclerosis (RRMS) patients, and 44 healthy controls (HCs) were recruited from ...
Xinli Wang +8 more
wiley +1 more source
Borate driven heterogeneous networks for porous elastomers with improved tribological and mechanical performances. [PDF]
Wu Y +13 more
europepmc +1 more source
Predicting combinations of drugs by exploiting graph embedding of heterogeneous networks. [PDF]
Song F, Tan S, Dou Z, Liu X, Ma X.
europepmc +1 more source
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source

